Open AccessRavulizumab-Cwvz (Ultomiris®)
Author(s) -
Sara M. Butler
Publication year - 2019
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000584128.99325.85
Subject(s) - eculizumab , paroxysmal nocturnal hemoglobinuria , medicine , hemoglobinuria , clinical endpoint , hemolysis , clinical trial , immunology , complement system , antibody